Industry Discovery & Development Partnership (IDDP) Program
Breakthrough T1D's IDDP Program funds for-profit companies to advance innovative research and development of new therapies for type 1 diabetes, focusing on translational and commercially viable solutions.
Funder: Breakthrough T1D
Due Dates: Rolling (Inquiries accepted year-round; timelines set upon invitation for full proposal)
Funding Amounts: Typically up to $3,000,000 total for up to 3 years; company matching funds required; no indirect costs allowed.
Summary: Supports for-profit organizations advancing research and development of innovative therapies for type 1 diabetes in alignment with Breakthrough T1D’s priority areas.
Key Information: Letter of Intent required before full proposal; contact Breakthrough T1D to discuss project scope and eligibility.
Description
The Industry Discovery & Development Partnership (IDDP) Program from Breakthrough T1D provides substantial funding and strategic support to for-profit organizations developing research projects closely aligned with Breakthrough T1D’s mission to accelerate innovative therapies for type 1 diabetes (T1D). This mechanism leverages the expertise and commercial capabilities of industry partners, aiming to bridge the gap between scientific discovery and product development. The program is designed to catalyze collaborations that facilitate the translation of promising research into impactful, commercially viable treatments and solutions for T1D.
